Mark Vander Wal

Mark Vander Wal is an Associate Professor at UCSF's Institute for Neurodegenerative Diseases with expertise in medicinal chemistry and drug development. He holds a PhD from the University of Ottawa and completed postdoctoral training at Princeton University. His research focuses on developing small molecule therapeutics for neurodegenerative disorders through innovative synthetic chemistry approaches.